Pharmaceutical Starch Sales

Pharmaceutical Starch Sales Market Outlook

The global pharmaceutical starch market is anticipated to witness substantial growth, with an expected market size reaching approximately USD 10 billion by 2035, advancing at a Compound Annual Growth Rate (CAGR) of around 5.6% during the forecast period from 2025 to 2035. This growth trajectory is attributed to the rising demand for excipients in the pharmaceutical industry, where starches are widely utilized for their versatility and functionalities. Furthermore, an increasing focus on drug formulation innovations and the growing number of chronic diseases are driving the need for effective pharmaceutical formulations. The expansion in the pharmaceutical and nutraceutical sectors, coupled with advancements in starch processing technologies, is set to bolster the market dynamics significantly. The increasing emphasis on sustainable and natural ingredients in drug formulations is also expected to contribute positively to the market growth.

Growth Factor of the Market

Several factors are contributing to the growth of the pharmaceutical starch market. First and foremost, the increasing prevalence of chronic diseases globally has led to a higher demand for effective pharmaceutical formulations, wherein starch serves as a crucial excipient. Additionally, the trend of personalized medicine necessitates the development of innovative drug delivery systems, where pharmaceutical starch plays a pivotal role due to its compatibility and functional properties. The rise in the geriatric population, who require various medications, further propels the need for pharmaceutical starch in developing various dosage forms. Moreover, advancements in research and development in starch modification techniques have led to the emergence of new products with enhanced functionalities, attracting the attention of pharmaceutical manufacturers. Lastly, the growing consumer awareness regarding natural ingredients in pharmaceuticals promotes the utilization of starch derived from natural sources, thereby fueling market growth.

Key Highlights of the Market

• The global pharmaceutical starch market is projected to reach USD 10 billion by 2035.
• CAGR is expected to be around 5.6% from 2025 to 2035.
• Increasing chronic disease prevalence drives demand for effective pharmaceutical formulations.
• Advancements in starch processing technologies enhance product offerings.
• The growing trend towards sustainable and natural ingredients supports market growth.

By Product Type

White Starch:

White starch is one of the most commonly used starch types in the pharmaceutical industry due to its excellent binding properties and neutral taste. It is derived primarily from corn, potatoes, or tapioca and serves as a critical excipient in the formulation of tablets and capsules. The demand for white starch is propelled by its efficacy in improving the flowability of powders and enhancing tablet hardness, which is essential for maintaining the integrity of pharmaceutical products during storage and transportation. Furthermore, white starch is often used as a filler and diluent in formulations, making it indispensable in the production of various dosage forms, thereby significantly contributing to the growth of the pharmaceutical starch market.

Yellow Starch:

Yellow starch, predominantly sourced from maize, is gaining traction in the pharmaceutical sector due to its unique properties. It is recognized for its ability to function as a disintegrant in tablet formulations, facilitating the rapid breakdown of dosage forms in the gastrointestinal tract. This is particularly crucial for drugs requiring quick absorption for effective therapeutic effects. As the pharmaceutical industry increasingly focuses on improving drug bioavailability, the application of yellow starch is expected to grow. Its natural origin also aligns with the market's trend towards using more organic and plant-based ingredients, making yellow starch a popular choice among formulators in the pharmaceutical industry.

Modified Starch:

Modified starches are extensively used in the pharmaceutical industry due to their tailored functional properties, which can be adjusted to meet specific formulation needs. These starches are chemically or physically altered to enhance their performance in applications such as binders, disintegrants, and stabilizers. The ability to modify the properties of starch, such as viscosity, solubility, and gelling capacity, ensures that formulators can create more effective and stable drug products. Given the rising demand for customized pharmaceutical formulations, the segment of modified starch is projected to witness significant growth in the coming years, driven by innovations in modification techniques and increasing R&D investments in the pharmaceutical sector.

Pre-gelatinized Starch:

Pre-gelatinized starch is gaining prominence in the pharmaceutical industry due to its unique ability to dissolve in cold water, making it highly advantageous for formulations requiring immediate release. This type of starch is processed to alter its gelatinization properties, resulting in a product that enhances the flowability of powders and improves tablet disintegration. Its application in both solid and liquid dosage forms is expected to grow as pharmaceutical companies seek faster and more efficient drug delivery systems. The increasing popularity of pre-gelatinized starch can also be attributed to its versatility and compatibility with various active pharmaceutical ingredients (APIs), positioning it as a preferred choice among formulators.

Others:

This category encompasses various other types of starch employed in pharmaceutical formulations, including specialty starches tailored for specific applications. These starches may include waxy corn starch, resistant starch, and others designed for niche markets. The diversity within this segment allows pharmaceutical manufacturers to choose starches that best fit their formulation requirements, which can vary based on the desired release profiles and stability needs of the drug products. As the pharmaceutical industry continues to evolve, the demand for innovative starch products that cater to specialized applications is anticipated to rise, supporting the growth of the 'Others' category in the pharmaceutical starch market.

By Application

Tablet Binder:

Tablet binders play a crucial role in the pharmaceutical industry, as they are responsible for holding the ingredients of a tablet together, ensuring the tablet's integrity during handling and delivery. Starch, particularly white and modified starches, is widely used as a binder due to its excellent adhesive properties and compatibility with various active pharmaceutical ingredients. The growing demand for solid dosage forms, coupled with the need for reliable binding agents, is anticipated to drive the usage of starches in this application segment. Additionally, the increasing focus on enhancing the mechanical strength of tablets is pushing formulators to explore the benefits of starch in developing more robust and durable formulations.

Disintegrant:

Disintegrants are essential in pharmaceutical formulations as they ensure the rapid breakdown of tablets upon contact with moisture. Starch, especially yellow and modified starches, is commonly used as a disintegrant due to their ability to swell and promote tablet disintegration effectively. This property is particularly important for fast-dissolving and immediate-release formulations, where quick drug absorption is paramount. With the rising consumer demand for medications that provide fast therapeutic effects, the market for starches utilized in disintegrant applications is expected to witness significant growth, fostering innovations in formulation strategies that incorporate starch-based disintegrants.

Filler & Diluent:

In pharmaceutical formulations, fillers and diluents are vital for adjusting the volume and mass of tablets and capsules, ensuring accurate dosing. Starch is widely used in this capacity due to its inert nature, cost-effectiveness, and ability to improve the flow properties of powders. As the pharmaceutical industry leans towards cost-efficient production methods and aims to maintain product consistency, the demand for starch-based fillers and diluents is projected to increase. Moreover, the ability of starch to enhance the overall stability of formulations plays a crucial role in its application as a filler, further supporting its significance in the pharmaceutical starch market.

Coating Agent:

Coating agents are utilized in pharmaceutical formulations to enhance the appearance, stability, and release profile of tablets and capsules. Starch, particularly modified starches, is increasingly employed as a coating agent due to its film-forming properties and ability to create protective barriers around drug formulations. The growing trend towards aesthetic appeal and branding in pharmaceutical products is driving the demand for innovative coating solutions that incorporate starch. Additionally, as regulatory bodies emphasize the importance of product quality and safety, the incorporation of starch in coating applications is expected to witness substantial growth, ultimately benefiting the pharmaceutical starch market.

Others:

This segment includes various other applications of pharmaceutical starch that extend beyond the main categories mentioned. These might encompass uses in controlled-release formulations, meal replacement products, and specialty applications in nutraceuticals. The versatility of starch as an excipient enables it to find applications in diverse pharmaceutical products, meeting the varied needs of manufacturers and consumers alike. The increasing trend towards multifunctional excipients is likely to propel innovations in starch applications, further emphasizing its role in enhancing the performance of pharmaceutical formulations.

By Distribution Channel

Pharmacies:

Pharmacies serve as a significant distribution channel for pharmaceutical starch, providing a direct link between manufacturers and consumers. They are where patients can obtain both prescription and over-the-counter medications that contain starch as an excipient. With the rise in the number of retail pharmacies and the increasing consumer inclination towards health and wellness products, pharmacy sales of pharmaceutical starches are expected to grow. The role of pharmacists in educating patients about the medications they dispense and the ingredients present in them further emphasizes the importance of pharmacies as a distribution channel in the pharmaceutical starch market.

Online Pharmacies:

The advent of online pharmacies has revolutionized the way consumers access pharmaceutical products, including those containing starch. This distribution channel allows patients to conveniently purchase medications from the comfort of their homes, expanding the market reach for pharmaceutical starch significantly. The increasing acceptance of e-commerce, coupled with the growing trend of digital health solutions, is driving the growth of online pharmacies. Furthermore, the ability to compare prices and read reviews online empowers consumers, making them more likely to choose products that utilize starch for their pharmaceutical formulations.

Drug Stores:

Drug stores represent another crucial distribution channel for pharmaceutical starch, catering to a broad consumer base seeking medications, health products, and wellness solutions. These stores often stock a wide range of pharmaceutical products, including those that utilize starch as an excipient. The growth of drug stores, alongside the rising consumer focus on health and wellness, enhances the availability of pharmaceutical products, thereby driving the demand for starch-based formulations. Additionally, the convenience of one-stop shopping for various health-related needs positions drug stores as a vital distribution channel within the pharmaceutical starch market.

Hospital Pharmacies:

Hospital pharmacies play a critical role in the distribution of pharmaceutical products, including those that contain starch as an excipient. They are responsible for preparing and dispensing medications for inpatients and outpatients, ensuring that patients receive their prescribed therapies. With the increasing complexity of drug formulations and the growing number of patients with chronic diseases, the reliance on hospital pharmacies for quality pharmaceutical products is expected to rise. The focus on patient safety and the necessity for effective drug delivery systems within healthcare settings further bolster the importance of hospital pharmacies as a distribution channel for pharmaceutical starch.

Others:

This category includes various alternative distribution channels such as wholesalers and distributors who facilitate the movement of pharmaceutical products from manufacturers to retailers and end-users. These channels are essential for streamlining the supply chain and ensuring the availability of pharmaceutical starch in various markets. As globalization increases and supply chains become more complex, the role of wholesalers and distributors in maintaining the flow of pharmaceutical products, including those containing starch, is likely to expand, supporting the overall growth of the pharmaceutical starch market.

By Ingredient Type

Potato Starch:

Potato starch is widely recognized for its excellent binding properties and is increasingly utilized in pharmaceutical formulations. Its natural origin and functionality make it an ideal excipient in tablet production, where it aids in binding and disintegration. The demand for potato starch is driven by its ability to enhance the stability and bioavailability of various active pharmaceutical ingredients (APIs). Furthermore, as the trend towards using natural and sustainable ingredients in pharmaceuticals grows, potato starch is gaining popularity among formulators looking for effective alternatives in their formulations. Its versatility allows it to be used in various dosage forms, further solidifying its position in the pharmaceutical starch market.

Corn Starch:

Corn starch is one of the most commonly used starches in the pharmaceutical industry, primarily due to its cost-effectiveness and functional attributes. It serves multiple roles, including that of a binder, filler, and disintegrant, making it a versatile excipient in tablet and capsule formulations. The increasing demand for corn starch can be attributed to its ability to improve the flow properties of powders and enhance the overall performance of pharmaceutical products. Additionally, as manufacturers continue to innovate in drug formulation technologies, corn starch’s adaptability and effectiveness ensure its sustained relevance in the pharmaceutical starch market.

Wheat Starch:

Wheat starch is also gaining traction in the pharmaceutical sector as an excipient due to its unique properties. It exhibits high viscosity and gelling capabilities, making it suitable for various applications, including binders and disintegrants in tablet formulations. The rising demand for wheat starch can be attributed to its ability to enhance the stability of formulations and improve the overall drug release profiles. Its performance in solid dosage forms, particularly in creating controlled-release products, positions wheat starch as an attractive ingredient in the pharmaceutical industry. As formulators seek to develop more effective drug delivery systems, the role of wheat starch is anticipated to expand in the coming years.

Rice Starch:

Rice starch is another valuable ingredient in the pharmaceutical market, known for its hypoallergenic properties and excellent thickening ability. It is particularly beneficial in formulations intended for sensitive populations, including children and the elderly, as it minimizes the risk of allergic reactions. The increasing demand for rice starch in pharmaceuticals can be attributed to its role as a binding agent and its compatibility with various APIs. As the trend towards cleaner label products grows, rice starch is increasingly being favored for its natural origins, making it a preferred choice among formulators looking to create safer and more effective pharmaceutical products.

Others:

This category includes various other starch types utilized in pharmaceutical applications, which may consist of specialty starches designed for specific functions or derived from alternative sources. The diversity of starch types available allows formulators to make selections based on the unique requirements of their formulations, such as enhancing viscosity, stability, or bioavailability. As the pharmaceutical industry continues to evolve and seek innovative solutions, the demand for alternative starch ingredients is expected to grow, further contributing to the breadth of options available in the pharmaceutical starch market.

By Region

The regional analysis of the pharmaceutical starch market indicates that North America is currently leading the market, accounting for approximately 35% of the total market share. This dominance is attributed to the robust pharmaceutical industry, characterized by high levels of research and development activities and significant investments in innovative drug formulations. The increasing prevalence of chronic diseases and the growing emphasis on personalized medicine in the region further bolster the demand for pharmaceutical starches. The CAGR for North America during the forecast period is estimated to be around 5.5%, reflecting a stable growth outlook due to ongoing advancements in pharmaceutical technologies.

In Europe, the pharmaceutical starch market is expected to witness significant growth, with a projected market share of around 30%. The region benefits from strong regulatory frameworks and a well-established pharmaceutical sector, driving the demand for high-quality excipients like starch. The increasing focus on the development of generic drugs and the rising awareness of natural ingredients among consumers are expected to contribute to market growth. The CAGR for Europe is projected to be slightly higher than that of North America, at approximately 5.8%, indicating a favorable environment for pharmaceutical starch utilization throughout the region. In Asia Pacific, the market is rapidly expanding, driven by the region's growth in pharmaceutical manufacturing capabilities and the rising adoption of modern healthcare practices.

Opportunities

The pharmaceutical starch market is poised for growth as the industry continues to evolve towards more advanced and innovative drug delivery systems. The increasing prevalence of chronic diseases worldwide presents a significant opportunity for the development of new pharmaceutical formulations that utilize starch as a key excipient. Moreover, the growing trend towards personalized medicine and the need for tailored drug delivery solutions allow manufacturers to explore the unique properties of various starches to enhance the efficacy and bioavailability of medications. Additionally, advancements in starch modification technologies create avenues for innovation, enabling the development of starches with enhanced functionalities that meet the specific requirements of modern pharmaceutical applications.

Furthermore, the rising awareness of health and wellness among consumers is driving the demand for natural ingredients in pharmaceutical products. As consumers increasingly seek out medications with cleaner labels and fewer synthetic additives, pharmaceutical starches derived from natural sources can serve as effective alternatives. This trend is likely to encourage manufacturers to invest in R&D efforts to explore novel starches and harness their benefits for drug formulations. Additionally, collaborations between pharmaceutical companies and starch suppliers can lead to the development of innovative products tailored to meet specific market demands, providing further growth opportunities within the pharmaceutical starch market.

Threats

While the pharmaceutical starch market presents several opportunities, it also faces challenges that could hinder growth. One of the primary threats is the volatility in raw material prices, which can affect the production costs of starches. Fluctuations in the prices of crops used to produce starch, such as corn and potatoes, can lead to increased costs for manufacturers and impact their profit margins. Additionally, stringent regulatory requirements concerning the quality and safety of pharmaceutical excipients may pose challenges for manufacturers seeking to comply with evolving standards. Failure to meet these regulations can result in product recalls and reputational damage, which could adversely affect market growth.

Moreover, the increasing competition from alternative excipients, including synthetic and semi-synthetic agents, may pose a threat to the market for pharmaceutical starch. As manufacturers continually seek cost-effective and efficient solutions for drug formulations, the adoption of alternatives could detract from the demand for starch-based excipients. Lastly, the ongoing developments in pharmaceutical technologies that prioritize rapid and efficient drug delivery systems may lead to shifts in preferences among formulators, potentially diminishing the role of traditional starches in future drug formulations.

Competitor Outlook

• Ingredion Incorporated
• FMC Corporation
• Roquette Frères
• AVEBE
• Cargill, Incorporated
• Glico Nutrition Co., Ltd.
• Universal Starch-Chem Allied Limited
• Groupe Limagrain
• Gum Arabic Factory
• Hindustan Starch
• Vimal Agro Products
• Starch Solutions LLC
• Rudolf GmbH
• Harlan Global Manufacturing
• Sunar Misir Sanayi A.S.

The pharmaceutical starch market is characterized by a competitive landscape comprising various key players, each striving to establish a significant presence through different growth strategies. Companies are increasingly investing in research and development to innovate and enhance their product offerings in response to evolving consumer demands and regulatory standards. Collaborations and partnerships within the industry are also becoming common as stakeholders seek to leverage each other's strengths to maximize their market potential. Additionally, mergers and acquisitions are frequently pursued by major players to expand their market share and diversify their product portfolios, positioning themselves as comprehensive solution providers in the pharmaceutical excipients market.

Ingredion Incorporated stands out as a leading player in the pharmaceutical starch market due to its extensive experience and a wide range of product offerings. The company specializes in developing starches and other ingredients for various applications, including pharmaceuticals. With a strong focus on innovation and sustainability, Ingredion is actively investing in research to develop next-generation starches that meet the specific needs of pharmaceutical formulators. The company's commitment to quality and customer satisfaction has earned it a reputation as a trusted supplier in the industry.

Roquette Frères is another prominent player known for its expertise in starch production and its commitment to delivering high-quality solutions for the pharmaceutical sector. The company's diverse portfolio includes a wide range of starches, including modified and pre-gelatinized starches, catering to various pharmaceutical applications. Roquette's global reach and dedication to sustainability position it as a strong competitor in the pharmaceutical starch market. Furthermore, the company actively collaborates with pharmaceutical manufacturers to develop customized solutions that enhance the performance and efficacy of their drug formulations.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 AVEBE
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Rudolf GmbH
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 FMC Corporation
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Groupe Limagrain
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Hindustan Starch
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Gum Arabic Factory
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Vimal Agro Products
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Starch Solutions LLC
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Cargill, Incorporated
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Ingredion Incorporated
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Roquette Frères
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Sunar Misir Sanayi A.S.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Glico Nutrition Co., Ltd.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Harlan Global Manufacturing
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Universal Starch-Chem Allied Limited
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Pharmaceutical Starch Sales Market, By Application
    • 6.1.1 Tablet Binder
    • 6.1.2 Disintegrant
    • 6.1.3 Filler & Diluent
    • 6.1.4 Coating Agent
    • 6.1.5 Others
  • 6.2 Pharmaceutical Starch Sales Market, By Product Type
    • 6.2.1 White Starch
    • 6.2.2 Yellow Starch
    • 6.2.3 Modified Starch
    • 6.2.4 Pre-gelatinized Starch
    • 6.2.5 Others
  • 6.3 Pharmaceutical Starch Sales Market, By Ingredient Type
    • 6.3.1 Potato Starch
    • 6.3.2 Corn Starch
    • 6.3.3 Wheat Starch
    • 6.3.4 Rice Starch
    • 6.3.5 Others
  • 6.4 Pharmaceutical Starch Sales Market, By Distribution Channel
    • 6.4.1 Pharmacies
    • 6.4.2 Online Pharmacies
    • 6.4.3 Drug Stores
    • 6.4.4 Hospital Pharmacies
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Pharmaceutical Starch Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Pharmaceutical Starch Sales market is categorized based on

By Product Type

• White Starch
• Yellow Starch
• Modified Starch
• Pre-gelatinized Starch
• Others

By Application

• Tablet Binder
• Disintegrant
• Filler & Diluent
• Coating Agent
• Others

By Distribution Channel

• Pharmacies
• Online Pharmacies
• Drug Stores
• Hospital Pharmacies
• Others

By Ingredient Type

• Potato Starch
• Corn Starch
• Wheat Starch
• Rice Starch
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Ingredion Incorporated
• FMC Corporation
• Roquette Frères
• AVEBE
• Cargill, Incorporated
• Glico Nutrition Co., Ltd.
• Universal Starch-Chem Allied Limited
• Groupe Limagrain
• Gum Arabic Factory
• Hindustan Starch
• Vimal Agro Products
• Starch Solutions LLC
• Rudolf GmbH
• Harlan Global Manufacturing
• Sunar Misir Sanayi A.S.